🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Pfizer, McDonald's Soar Premarket; Biogen Slumps

Published 11/09/2020, 08:04 AM
Updated 11/09/2020, 08:05 AM
© Reuters.
FDX
-
MCD
-
AAPL
-
AMZN
-
BIIB
-
PFE
-
UPS
-
SPG
-
DAL
-
UAL
-
BRKa
-
CUK
-
RCL
-
NCLH
-
AAL
-
AMC
-
WEED
-
ZM
-
PTON
-
BNTX
-

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Monday, November 9th. Please refresh for updates.

  • Pfizer (NYSE:PFE) stock soared 13% after the pharma giant announced that its Covid-19 vaccine candidate, made in conjunction with Biontech (NASDAQ:BNTX), was 90% effective in a late-stage trial. Biontech stock was up 25.5%.

  • Biogen (NASDAQ:BIIB) stock slumped 27% after a U.S. Food and Drug Administration advisory panel was critical of the efficacy of the company’s experimental Alzheimer’s disease therapy, casting doubts over its approval.

  • Zoom (NASDAQ:ZM) stock fell 13% and Peloton (NASDAQ:PTON) stock dropped 12% as ‘stay-at-home’ companies slumped on the positive vaccine news.

  • American Airlines (NASDAQ:AAL), United Airlines (NASDAQ:UAL) and Delta Air Lines (NYSE:DAL) stock soared over 15% on the Pfizer news, amid hope that a widely-available vaccine will allow a quicker rebound in air travel. 

  • Carnival (NYSE:CUK), Royal Caribbean (NYSE:RCL) and Norwegian Cruise Line (NYSE:NCLH) stock all rose over 20% on hope that the positive news about Pfizer’s vaccine will lead to their cruise liners sailing again sooner than originally thought. 

  • Simon Property (NYSE:SPG) rose 16% as the same news breathed life into threatened shopping malls. Amazon (NASDAQ:AMZN) stock fell 2.3%, while FedEx (NYSE:FDX) and United Parcel Service (NYSE:UPS) stock - two other winners of the shift to online shopping - gave up 3.1% and 1.6% respectively.
  • Movie theater AMC Entertainment (NYSE:AMC) stock rose 75% on hopes for a quick reopening of theaters and a return to studios distributing new releases in the traditional way.
  • Berkshire Hathaway (NYSE:BRKa) stock rose 5.8% after Warren Buffett’s conglomerate bought back $9 billion of its own stock in the third quarter, nearly doubling the record buyback from the second quarter.

  • Apple (NASDAQ:AAPL) stock rose 1.4%, underperforming the wider market as the iPhone maker suspended new business with key supplier Pegatron after finding that the Taiwanese company violated its rules related to student worker programs at its China facilities.

  • McDonald’s (NYSE:MCD) stock rose 5.4% after the fast-food giant reported strong third-quarter earnings and increased its dividend.

  • Canopy Growth (NYSE:CGC) stock rose 11% after the Canadian cannabis company posted a smaller-than-expected loss in its fiscal second quarter, while revenue grew more than anticipated.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.